Literature DB >> 33173458

Molecular Blood Group Screening in Donors from Arabian Countries and Iran Using High-Throughput MALDI-TOF Mass Spectrometry and PCR-SSP.

Brigitte Katharina Flesch1,2, Vanessa Scherer1, Burkhard Just2, Andreas Opitz1, Oswin Ochmann1, Anne Janson1, Monika Steitz1, Thomas Zeiler2.   

Abstract

BACKGROUND AND AIMS: Only little is known about blood groups other than ABO blood groups and Rhesus factors in Arabian countries and Iran. During the last years, increased migration to Central Europe has put a focus on the question how to guarantee blood supply for patients from these countries, particularly because hemoglobinopathies with the need of regular blood support are more frequent in patients from that region. Therefore, blood group allele frequencies should be determined in individuals from Arabian countries and Iran by molecular typing and compared to a German rare donor panel.
METHODS: 1,111 samples including 800 individuals from Syria, 147 from Iran, 123 from the Arabian Peninsula, and 41 from Northern African countries were included in a MALDI-TOF MS assay to detect polymorphisms coding for Kk, Fy(a/b), Fy<sub>null</sub>, C<sub>w</sub>, Jk(a/b), Jo(a+/a-), Lu(a/b), Lu(8/14), Ss, Do(a/b), Co(a/b), In(a/b), Js(a/b), Kp(a/b), and variant alleles RHCE*c.697C>G and RHCE *c.733C>G. Yt(a/b), S-s-U-, Vel<sub>null</sub>, Co<sub>null</sub>, and RHCE *c.667G>T were tested by PCR-SSP.
RESULTS: Of the Arabian donors, 2% were homozygous for the FY *02.01N allele (Fy<sub>null</sub>), and 15.7% carried the heterozygous mutation. However, 0.8% of the German donors also carried 1 copy of the allele. 3.6% of all and 29.3% of Northern African donors were heterozygous for the RHCE *c.733C>G substitution, 0.4% of the Syrian probands were heterozygous for DO *01/DO *01.-05, a genotype that was lacking in German donors. Whereas the KEL *02.06 allele coding for the Js(a) phenotype was missing in Germans; 0.8% of the Syrian donors carried 1 copy of this allele. 1.8% of the Syrian but only 0.3% of the German donors were negative for YT *01. One donor from Northern Africa homo-zygously carried the GYPB *270+5g>t mutation, inducing the S-s-U+<sup>w</sup> phenotype, and in 2 German donors a GYPB *c.161G>A exchange, which induces the Mit+ phenotype, caused a GYPB *03 allele dropout in the MALDI assay. The overall failure rate of the Arabian panel was 0.4%.
CONCLUSIONS: Some blood group alleles that are largely lacking in Europeans but had been described in African individuals are present in Arabian populations at a somewhat lower frequency. In single cases, it could be challenging to provide immunized Arabian patients with compatible blood.
Copyright © 2020 by S. Karger AG, Basel.

Entities:  

Keywords:  Arabian donors; Blood groups; Donor screening; Genotyping; MALDI-TOF MS; Molecular blood group typing; PCR

Year:  2020        PMID: 33173458      PMCID: PMC7590766          DOI: 10.1159/000505495

Source DB:  PubMed          Journal:  Transfus Med Hemother        ISSN: 1660-3796            Impact factor:   3.747


  40 in total

1.  High-throughput multiplex PCR genotyping for 35 red blood cell antigens in blood donors.

Authors:  C Jungbauer; C M Hobel; D W M Schwartz; W R Mayr
Journal:  Vox Sang       Date:  2011-11-21       Impact factor: 2.144

2.  Rhesus and Kell Phenotyping of Voluntary Blood Donors: Foundation of a Donor Data Bank.

Authors:  Farheen Karim; Bushra Moiz; Fahmida Jan Muhammad; Fatima Ausat; Mohammad Khurshid
Journal:  J Coll Physicians Surg Pak       Date:  2015-10       Impact factor: 0.711

3.  High-throughput multiplex single-nucleotide polymorphism analysis for red cell and platelet antigen genotypes.

Authors:  G A Denomme; M Van Oene
Journal:  Transfusion       Date:  2005-05       Impact factor: 3.157

Review 4.  Emerging strategies of blood group genotyping for patients with hemoglobinopathies.

Authors:  A Belsito; K Magnussen; C Napoli
Journal:  Transfus Apher Sci       Date:  2016-12-09       Impact factor: 1.764

5.  Blood group typing in five Afghan populations in the North Hindu-Kush region: implications for blood transfusion practice.

Authors:  S Mazières; S A Temory; H Vasseur; P Gallian; J Di Cristofaro; J Chiaroni
Journal:  Transfus Med       Date:  2013-04-11       Impact factor: 2.019

Review 6.  Is Next Generation Sequencing the future of blood group testing?

Authors:  Louise Tilley; Shane Grimsley
Journal:  Transfus Apher Sci       Date:  2014-03-07       Impact factor: 1.764

7.  The AQP1 del601G mutation in different European Romani (Gypsy) populations.

Authors:  Brigitte K Flesch; Bharti Morar; David Comas; Eduardo Muñiz-Diaz; Núria Nogués; Luba Kalaydjieva
Journal:  Blood Transfus       Date:  2016-05-11       Impact factor: 3.443

Review 8.  International rare donor panels: a review.

Authors:  S Nance; E A Scharberg; N Thornton; V Yahalom; I Sareneva; C Lomas-Francis
Journal:  Vox Sang       Date:  2015-12-21       Impact factor: 2.144

9.  Sequence-Based Typing of Human Blood Groups.

Authors:  Axel Seltsam; Andrea Doescher
Journal:  Transfus Med Hemother       Date:  2009-05-14       Impact factor: 3.747

10.  Towards a Regional Registry of Extended Typed Blood Donors: Molecular Typing for Blood Group, Platelet and Granulocyte Antigens.

Authors:  Jan Portegys; Gabi Rink; Pia Bloos; Erwin A Scharberg; Harald Klüter; Peter Bugert
Journal:  Transfus Med Hemother       Date:  2018-09-24       Impact factor: 3.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.